Formoterol (INN) or eformoterol (former BAN) is a long-acting β2-agonist used in the management of asthma and/or chronic obstructive pulmonary disease (COPD). It is marketed in four forms: a dry-powder inhaler (DPI), metered dose inhaler (MDI), an oral tablet, and as an inhalation solution, under various trade names including Foradil/Foradile (Novartis), Oxis (AstraZeneca), Atock (Astellas) and Perforomist (Dey).
4 edits since May 19, 2008. Last edited Jul 26, 2008 by Carlo Banez (49).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Formoterol. See this site's terms for details.